Patients, the public, and even health professionals enthu-siastically support screening for disease, especially screen-ing for cancer. Unfortunately, whether many members of these groups fully understand the benefits and risks that would allow an informed decision is not clear. This has not, however, dampened the enthusiasm for screening. A decade ago, Schwartz and colleagues (1) found that 87 % of a national sample of adults believed that routine cancer screening is al-most always a good idea and 74 % said that early detection saves lives most or all of the time—to the point that more than one third considered an 80-year-old person who declined screening to be irresponsible. As chair of the U.S. Preventive Services Task Force when the draf...
The information provided in this handout does not necessarily reflect the views of the University of...
PSA screening remains highly controversial due to several important disadvantages. More PSA is produ...
textabstractSince the first publication describing the identification of prostate-specific antigen (...
Prostate cancer is a devastating illness. Approximately28 000 American men will die of it this year ...
Universal screening for prostate cancer (Pca) using prostate-specific antigen-based testing is not r...
IntroductionShared decision-making is widely recommended when men are considering prostate cancer sc...
BACKGROUND: Screening with prostate-specific antigen (PSA) can reduce prostate cancer mortality, but...
The information provided in this handout does not necessarily reflect the views of the University of...
ObjectiveProstate specific antigen (PSA) screening for prostate cancer screening is not uniformly re...
Routine cancer screening with prostate-specific antigen (PSA) is controversial, and practice guideli...
Background:Screening with prostate-specific antigen (PSA) can reduce prostate cancer mortality, but ...
men. It rarely causes death in men younger than 50 years; most deaths associated with it occur in me...
Prostate cancer screening is an ever-changing field because the benefits of using PSA as a screening...
Prostate-specific antigen (PSA) testing of men at normal risk of prostate cancer is one of the most ...
PURPOSE Informed decision making is recommended for prostate cancer screen-ing. I wanted to examine ...
The information provided in this handout does not necessarily reflect the views of the University of...
PSA screening remains highly controversial due to several important disadvantages. More PSA is produ...
textabstractSince the first publication describing the identification of prostate-specific antigen (...
Prostate cancer is a devastating illness. Approximately28 000 American men will die of it this year ...
Universal screening for prostate cancer (Pca) using prostate-specific antigen-based testing is not r...
IntroductionShared decision-making is widely recommended when men are considering prostate cancer sc...
BACKGROUND: Screening with prostate-specific antigen (PSA) can reduce prostate cancer mortality, but...
The information provided in this handout does not necessarily reflect the views of the University of...
ObjectiveProstate specific antigen (PSA) screening for prostate cancer screening is not uniformly re...
Routine cancer screening with prostate-specific antigen (PSA) is controversial, and practice guideli...
Background:Screening with prostate-specific antigen (PSA) can reduce prostate cancer mortality, but ...
men. It rarely causes death in men younger than 50 years; most deaths associated with it occur in me...
Prostate cancer screening is an ever-changing field because the benefits of using PSA as a screening...
Prostate-specific antigen (PSA) testing of men at normal risk of prostate cancer is one of the most ...
PURPOSE Informed decision making is recommended for prostate cancer screen-ing. I wanted to examine ...
The information provided in this handout does not necessarily reflect the views of the University of...
PSA screening remains highly controversial due to several important disadvantages. More PSA is produ...
textabstractSince the first publication describing the identification of prostate-specific antigen (...